Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics

Di uno scrittore di uomini misteriosi

Descrizione

Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: microtomographic, histological and immunohistochemical characterization
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
IJMS, Free Full-Text
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Pathophysiology of Medication‐Related Osteonecrosis of the Jaw—A Minireview - Tetradis - 2023 - JBMR Plus - Wiley Online Library
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Infection and Medication-related Osteonecrosis of the Jaw - H. Katsarelis, N.P. Shah, D.K. Dhariwal, M. Pazianas, 2015
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Cells, Free Full-Text
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Frontiers Inflammasomes in Alveolar Bone Loss
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Antioxidants, Free Full-Text
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Frontiers Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw
Osteonecrosis development by tooth extraction in zoledronate treated mice  is inhibited by active vitamin D analogues, anti-inflammatory agents or  antibiotics
Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using equilibrium competing inert hydroxymethylene diphosphonate
da per adulto (il prezzo varia in base alle dimensioni del gruppo)